Record citatie

APA (7e ed.) Bronvermelding
Rybak, M. J., Houlihan, H. H., Mercier, R. C., & Kaatz, G. W. (1997). Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Antimicrob Agents Chemother.
Chicago (17e ed.) Bronvermelding
Rybak, M J., H H. Houlihan, R C. Mercier, en G W. Kaatz. "Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) Administered by Intermittent Versus Continuous Infusion Against Staphylococcus Aureus-infected Fibrin-platelet Clots in an in Vitro Infection Model." Antimicrob Agents Chemother 1997.
MLA (9e ed.) Bronvermelding
Rybak, M J., et al. "Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) Administered by Intermittent Versus Continuous Infusion Against Staphylococcus Aureus-infected Fibrin-platelet Clots in an in Vitro Infection Model." Antimicrob Agents Chemother, 1997.
Let op: Deze citaties zijn niet altijd 100% accuraat.